T1	Participants 97 131	patients with rheumatoid arthritis
T2	Participants 162 204	1 or more tumor necrosis factor inhibitors
T3	Participants 428 540	patients with rheumatoid arthritis (RA) who had an inadequate response to tumor necrosis factor (TNF) inhibitors
T4	Participants 1232 1255	A total of 480 patients
